Paediatric Non-Alcoholic Fatty Liver Disease

A Clinical Trial of Gemcabene in Paediatric Patients with Non-Alcoholic Fatty Liver Disease Has Been Stopped Following Safety Concerns

Post author:Anna Hewitt
Post published:August 13, 2018
Post category:Rare Disease

Gemphire Therapeutics Inc. has been recommended to stop a clinical trial by the Data and Safety Monitoring Board at Emory University School of Medicine. The clinical trial, which ran into…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More